drugset / Trial / NCT03352700

Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy

NCT03352700

Phase 4 Unknown 580 enrolled Changhai Hospital
RandomizedParallel-groupSingle-blindScreening

Summary

In this randomized controlled study, consecutive outpatients scheduled for elective colonoscopy were randomized into two groups. Group A patients (n = 300) used only 3L PEG before colonoscopy. Patients in group B (n = 300) were additionally advised to Dyclonine Hydrochloride Mucilage plus 3L PEG, The overall quality of colonoscopy cleaning was evaluated using the Boston Bowel Preparation Scale by a single endoscopist who was blinded to the intervention. Visibility was blindly assessed for the amount of air bubbles and adenoma detection rate (ADR). Difficulty of procedure, and adverse events were also evaluated.

Timeline

Start
2017-12-01
Primary completion
2018-01-01
Completion
2018-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dyclonine Small molecule
Comparator PEG Unknown 3000 ml

Indications